These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32923854)

  • 1. Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations.
    Hu C; Dignam JJ
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32923854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities in biomarker-driven trials: adaptive randomization.
    Park Y
    Ann Transl Med; 2022 Sep; 10(18):1035. PubMed ID: 36267794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations.
    Le-Rademacher J; Dahlberg S; Lee JJ; Adjei AA; Mandrekar SJ
    J Thorac Oncol; 2018 Nov; 13(11):1625-1637. PubMed ID: 30194034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer.
    Snowdon C; Kernaghan S; Moretti L; Turner NC; Ring A; Wilkinson K; Martin S; Foster S; Kilburn LS; Bliss JM
    Trials; 2022 May; 23(1):372. PubMed ID: 35526005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
    Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
    Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
    Moore DC; Guinigundo AS
    J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
    Schiavone F; Bathia R; Letchemanan K; Masters L; Amos C; Bara A; Brown L; Gilson C; Pugh C; Atako N; Hudson F; Parmar M; Langley R; Kaplan RS; Parker C; Attard G; Clarke NW; Gillessen S; James ND; Maughan T; Sydes MR;
    Trials; 2019 May; 20(1):264. PubMed ID: 31138317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
    Yin J; Shen S; Shi Q
    Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
    Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
    Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and analysis of umbrella trials: Where do we stand?
    Ouma LO; Wason JMS; Zheng H; Wilson N; Grayling M
    Front Med (Lausanne); 2022; 9():1037439. PubMed ID: 36313987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive clinical trial designs in oncology.
    Zang Y; Lee JJ
    Chin Clin Oncol; 2014 Dec; 3(4):. PubMed ID: 25811018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive clinical trial designs in oncology.
    Zang Y; Lee JJ
    Chin Clin Oncol; 2014 Dec; 3(4):49. PubMed ID: 25841530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of adaptive strategy and adaptive design for biomarker-facilitated patient selection in pharmacogenomic or pharmacogenetic clinical development program.
    Wang SJ
    J Formos Med Assoc; 2008 Dec; 107(12 Suppl):19-27. PubMed ID: 19129042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker-Driven Oncology Trial Design and Subgroup Characterization: Challenges and Potential Solutions.
    Wang J; Yu B; Dou YN; Mascaro J
    JCO Precis Oncol; 2024 Jun; 8():e2400116. PubMed ID: 38848518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.
    Mandrekar SJ; Sargent DJ
    J Clin Oncol; 2009 Aug; 27(24):4027-34. PubMed ID: 19597023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.
    Israel E; Denlinger LC; Bacharier LB; LaVange LM; Moore WC; Peters MC; Georas SN; Wright RJ; Mauger DT; Noel P; Akuthota P; Bach J; Bleecker ER; Cardet JC; Carr TF; Castro M; Cinelli A; Comhair SAA; Covar RA; Alexander LC; DiMango EA; Erzurum SC; Fahy JV; Fajt ML; Gaston BM; Hoffman EA; Holguin F; Jackson DJ; Jain S; Jarjour NN; Ji Y; Kenyon NJ; Kosorok MR; Kraft M; Krishnan JA; Kumar R; Liu AH; Liu MC; Ly NP; Marquis MA; Martinez FD; Moy JN; O'Neal WK; Ortega VE; Peden DB; Phipatanakul W; Ross K; Smith LJ; Szefler SJ; Teague WG; Tulchinsky AF; Vijayanand P; Wechsler ME; Wenzel SE; White SR; Zeki AA; Ivanova A
    J Allergy Clin Immunol; 2021 May; 147(5):1594-1601. PubMed ID: 33667479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.